Naperville, IL -- (SBWIRE) -- 09/28/2012 -- IMPAX Laboratories, Inc. - Product Pipeline Review - 2012 provides data on the IMPAX Laboratories, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- IMPAX Laboratories, Inc. - Brief IMPAX Laboratories, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of IMPAX Laboratories, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of IMPAX Laboratories, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the IMPAX Laboratories, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate IMPAX Laboratories, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of IMPAX Laboratories, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the IMPAX Laboratories, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with IMPAX Laboratories, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of IMPAX Laboratories, Inc. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of IMPAX Laboratories, Inc.; IMPAX Laboratories, Inc. - Key Therapeutics; IMPAX Laboratories, Inc. - Pipeline Overview and Promising Molecules; IMPAX Laboratories, Inc. - News; IMPAX Laboratories, Inc. - Latest Updates; IMPAX Laboratories, Inc. - Pipeline; IMPAX Laboratories, Inc. - Discontinued/Dormant Projects

To view table of contents for this market report please visit:
http://www.reportstack.com/product/90055/impax-laboratories-inc-product-pipeline-review-2012.html